Immunique

A Senolytic NK Platform for Recovery Beyond Treatment

PRIME-NK is an innate immunity-based NK cell platform designed toively eliminate therapy-induced senescent
(TIS) cells that accumulate following cancer treatment. By reducing chronic inflammation and restoring immune 
balance, PRIME-NK promotes tissue regeneration and functional recovery.
Rather than simply managing symptoms, PRIME-NK targets the underlying biological mechanisms that limit recovery 
after treatment, supporting the restoration of immune health and long-term resilience.

Key Advantages of PRIME-NK

✓  Selective Clearance of Senescent Cells
✓  Enhanced Senescent Cell Recognition
✓  Immune Restoration
✓  Feeder-Free Manufacturing
✓  Clinical Translation 

A Regenerative Medicine Strategy for Recovery Beyond Treatment

IMMUNIQUE is advancing a regenerative medicine strategy built around PRIME-NK to promote immune restoration
and improve quality of life following cancer treatment.
Through carefully designed regenerative medicine programs, we generate early clinical experience and real-world
evidence while investigating the biological mechanisms that drive recovery, including therapy-induced senescence (TIS).
These insights strengthen our understanding of post-treatment recovery and accelerate the clinical translation of PRIME-NK into next-generation therapeutics.

Strategic Objectives

✓ Generate Early Clinical Experience
Build clinical evidence through regenerative medicine programs supported by exploratory biomarkers.

✓ Establish Real-World Evidence
Collect real-world data (RWD) to better understand the biology of post-treatment recovery.

✓ Advance Recovery Biology
Refine therapeutic strategies targeting therapy-induced senescence and immune restoration.

✓ Accelerate Clinical Translation
Support the future clinical development of PRIME-NK through translational research and clinical insights.

※ Regenerative medicine services are provided in accordance with applicable regulatory requirements and institutional guidelines

An AI-Driven Cytokine Mimetic Platform for Precision Immunomodulation

IMMUNOKINE is a next-generation cytokine mimetic platform that combines AI-driven molecular design, structural
biology, and peptide engineering to precisely regulate immune signaling based on disease biology.
Rather than simply suppressing or activating immune responses, IMMUNOKINE is designed to reprogram immune
signaling through rationally engineered cytokine mimetics, enabling moreive and effective immunomodulation .
With broad applicability across immune-mediated diseases, IMMUNOKINE serves as a scalable discovery platform for developing next-generation precision immunotherapies. 

An Autologous Treg Platform for Restoring Immune Tolerance

AUTO-Treg is a precision autologous regulatory T cell (Treg) platform designed to restore immune tolerance
by enhancing the function and persistence of a patient's own Tregs. 
Throughive regulation of pathological immune responses,
AUTO-Treg aims to re-establish long-term immune balance while preserving protective immunity.
Moving beyond conventional immunosuppressive therapies,
AUTO-Treg addresses the underlying mechanisms of immune dysregulation rather than simply controlling symptoms.
Supported by advanced Treg expansion technologies,reproducible manufacturing, and robust quality systems,
IMMUNIQUE is building a scalable next-generation Treg platform for autoimmune and chronic inflammatory diseases. 

A Regenerative Medicine Strategy for Restoring Immune Tolerance

IMMUNIQUE is advancing an AUTO-Treg-based regenerative medicine strategy to restore immune tolerance
and re-establish long-term immune regulation in patients with autoimmune diseases.
Through regenerative medicine programs, we generate early clinical experience and real-world evidence while
investigating the biological mechanisms underlying Treg function, immune tolerance, and durable immune regulation.
These insights support future indication expansion and accelerate the clinical translation of next generation Treg cell therapies.

Strategic Objectives

✓ Generate Early Clinical Experience
Build clinical evidence through regenerative medicine programs.

✓ Establish Real-World Evidence
Generate real-world data (RWD) to deepen our understanding of Treg biology and immune tolerance.

✓ Advance Immune Tolerance Restoration
Refine Treg-based therapeutic strategies through translational research.

✓ Accelerate Clinical Translation
Support future clinical development and indication expansion of AUTO-Treg therapies.

※ Regenerative medicine services are provided in accordance with applicable laws, regulations, and institutional guidelines.